Neurofibromatosis: New Clinical Challenges in the Era of COVID-19

Neurofibromatosis: New Clinical Challenges in the Era of COVID-19

Rare diseases constitute a wide range of disorders thus defined for their low prevalence. However, taken together, rare diseases impact a considerable percentage of the world population, thus representing a public healthcare problem. In particular, neurofibromatoses are autosomal-dominant genetic di...

Full description

Bibliographic Details
Main Authors: Alessio Ardizzone, Anna Paola Capra, Michela Campolo, Alessia Filippone, Emanuela Esposito, Silvana Briuglia
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
rare diseases
neurofibromatosis
COVID-19
clinical care
personalized medicine
pharmacogenetics
Online Access:https://www.mdpi.com/2227-9059/10/5/940

Internet

https://www.mdpi.com/2227-9059/10/5/940

Similar Items